These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 24928441)

  • 61. Impaired PRC2 activity promotes transcriptional instability and favors breast tumorigenesis.
    Wassef M; Rodilla V; Teissandier A; Zeitouni B; Gruel N; Sadacca B; Irondelle M; Charruel M; Ducos B; Michaud A; Caron M; Marangoni E; Chavrier P; Le Tourneau C; Kamal M; Pasmant E; Vidaud M; Servant N; Reyal F; Meseure D; Vincent-Salomon A; Fre S; Margueron R
    Genes Dev; 2015 Dec; 29(24):2547-62. PubMed ID: 26637281
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Oncogenic enhancer of zeste homolog 2 is an actionable target in patients with non-small cell lung cancer.
    Shi B; Behrens C; Vaghani V; Riquelme EM; Rodriguez-Canales J; Kadara H; Lin H; Lee J; Liu H; Wistuba I; Simon G
    Cancer Med; 2019 Oct; 8(14):6383-6392. PubMed ID: 31456359
    [TBL] [Abstract][Full Text] [Related]  

  • 63. EZH2 has a non-catalytic and PRC2-independent role in stabilizing DDB2 to promote nucleotide excision repair.
    Koyen AE; Madden MZ; Park D; Minten EV; Kapoor-Vazirani P; Werner E; Pfister NT; Haji-Seyed-Javadi R; Zhang H; Xu J; Deng N; Duong DM; Pecen TJ; Frazier Z; Nagel ZD; Lazaro JB; Mouw KW; Seyfried NT; Moreno CS; Owonikoko TK; Deng X; Yu DS
    Oncogene; 2020 Jun; 39(25):4798-4813. PubMed ID: 32457468
    [TBL] [Abstract][Full Text] [Related]  

  • 64. EZH2 is increased in paediatric T-cell acute lymphoblastic leukemia and is a suitable molecular target in combination treatment approaches.
    D'Angelo V; Iannotta A; Ramaglia M; Lombardi A; Zarone MR; Desiderio V; Affinita MC; Pecoraro G; Di Martino M; Indolfi P; Casale F; Caraglia M
    J Exp Clin Cancer Res; 2015 Aug; 34(1):83. PubMed ID: 26268310
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Noncanonical Functions of the Polycomb Group Protein EZH2 in Breast Cancer.
    Anwar T; Gonzalez ME; Kleer CG
    Am J Pathol; 2021 May; 191(5):774-783. PubMed ID: 33556366
    [TBL] [Abstract][Full Text] [Related]  

  • 66. BRCA1 is a negative modulator of the PRC2 complex.
    Wang L; Zeng X; Chen S; Ding L; Zhong J; Zhao JC; Wang L; Sarver A; Koller A; Zhi J; Ma Y; Yu J; Chen J; Huang H
    EMBO J; 2013 May; 32(11):1584-97. PubMed ID: 23624935
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Linker histone H1.2 establishes chromatin compaction and gene silencing through recognition of H3K27me3.
    Kim JM; Kim K; Punj V; Liang G; Ulmer TS; Lu W; An W
    Sci Rep; 2015 Nov; 5():16714. PubMed ID: 26581166
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The Y641C mutation of EZH2 alters substrate specificity for histone H3 lysine 27 methylation states.
    Wigle TJ; Knutson SK; Jin L; Kuntz KW; Pollock RM; Richon VM; Copeland RA; Scott MP
    FEBS Lett; 2011 Oct; 585(19):3011-4. PubMed ID: 21856302
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Wedelolactone Targets EZH2-mediated Histone H3K27 Methylation in Mantle Cell Lymphoma.
    Romanchikova N; Trapencieris P
    Anticancer Res; 2019 Aug; 39(8):4179-4184. PubMed ID: 31366503
    [TBL] [Abstract][Full Text] [Related]  

  • 70. STAT3-driven transcription depends upon the dimethylation of K49 by EZH2.
    Dasgupta M; Dermawan JK; Willard B; Stark GR
    Proc Natl Acad Sci U S A; 2015 Mar; 112(13):3985-90. PubMed ID: 25767098
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Suppression of lung adenocarcinoma through menin and polycomb gene-mediated repression of growth factor pleiotrophin.
    Gao SB; Feng ZJ; Xu B; Wu Y; Yin P; Yang Y; Hua X; Jin GH
    Oncogene; 2009 Nov; 28(46):4095-104. PubMed ID: 19749796
    [TBL] [Abstract][Full Text] [Related]  

  • 72. An allosteric PRC2 inhibitor targeting the H3K27me3 binding pocket of EED.
    Qi W; Zhao K; Gu J; Huang Y; Wang Y; Zhang H; Zhang M; Zhang J; Yu Z; Li L; Teng L; Chuai S; Zhang C; Zhao M; Chan H; Chen Z; Fang D; Fei Q; Feng L; Feng L; Gao Y; Ge H; Ge X; Li G; Lingel A; Lin Y; Liu Y; Luo F; Shi M; Wang L; Wang Z; Yu Y; Zeng J; Zeng C; Zhang L; Zhang Q; Zhou S; Oyang C; Atadja P; Li E
    Nat Chem Biol; 2017 Apr; 13(4):381-388. PubMed ID: 28135235
    [TBL] [Abstract][Full Text] [Related]  

  • 73. DZNep, inhibitor of S-adenosylhomocysteine hydrolase, down-regulates expression of SETDB1 H3K9me3 HMTase in human lung cancer cells.
    Lee JK; Kim KC
    Biochem Biophys Res Commun; 2013 Sep; 438(4):647-52. PubMed ID: 23933322
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Wedelolactone disrupts the interaction of EZH2-EED complex and inhibits PRC2-dependent cancer.
    Chen H; Gao S; Li J; Liu D; Sheng C; Yao C; Jiang W; Wu J; Chen S; Huang W
    Oncotarget; 2015 May; 6(15):13049-59. PubMed ID: 25944687
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A Potential Epigenetic Therapy for NSCLC.
    Cancer Discov; 2015 Apr; 5(4):341. PubMed ID: 25724377
    [TBL] [Abstract][Full Text] [Related]  

  • 76. PRC2-Mediated Epigenetic Suppression of Type I IFN-STAT2 Signaling Impairs Antitumor Immunity in Luminal Breast Cancer.
    Hong J; Lee JH; Zhang Z; Wu Y; Yang M; Liao Y; de la Rosa R; Scheirer J; Pechacek D; Zhang N; Xu Z; Curiel T; Tan X; Huang TH; Xu K
    Cancer Res; 2022 Dec; 82(24):4624-4640. PubMed ID: 36222718
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Structural Basis of the Interaction Between Ubiquitin Specific Protease 7 and Enhancer of Zeste Homolog 2.
    Gagarina V; Bojagora A; Lacdao IK; Luthra N; Pfoh R; Mohseni S; Chaharlangi D; Tan N; Saridakis V
    J Mol Biol; 2020 Feb; 432(4):897-912. PubMed ID: 31866294
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Ezh2 is required for neural crest-derived cartilage and bone formation.
    Schwarz D; Varum S; Zemke M; Schöler A; Baggiolini A; Draganova K; Koseki H; Schübeler D; Sommer L
    Development; 2014 Feb; 141(4):867-77. PubMed ID: 24496623
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Non-Canonical EZH2 Transcriptionally Activates RelB in Triple Negative Breast Cancer.
    Lawrence CL; Baldwin AS
    PLoS One; 2016; 11(10):e0165005. PubMed ID: 27764181
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Involvement of EZH2, SUV39H1, G9a and associated molecules in pathogenesis of urethane induced mouse lung tumors: potential targets for cancer control.
    Pandey M; Sahay S; Tiwari P; Upadhyay DS; Sultana S; Gupta KP
    Toxicol Appl Pharmacol; 2014 Oct; 280(2):296-304. PubMed ID: 25168426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.